Photodynamic therapy (PDT) is a new evidence-based treatment modality available for choroidal neovascularisation (CNV) secondary to age-related macular degeneratin (AMD). Eligibility for PDT is based on the morphological classification of the neovascular complex, the benefit being greater in classic with no occult lesions. Lesion size is also shown to be a predictive factor for treatment benefit. This retrospective case series looked at effect of initial and final lesion size on the visual outcome of patients with subfoveal classic with no occult CNV and found that increasing initial and final lesion size is associated with poorer visual outcome.
Introduction
Choroidal neovasularisation (CNV) secondary to age-related macular degeneration (AMD) is the leading cause of severe visual loss in the elderly in the Western world. 1 One of the evidence-based treatment options available for this condition is photodynamic therapy (PDT). The treatment for age-related macular degeneration with PDT (TAP) study group confirmed that PDT reduces the risk of moderate to severe visual loss in subfoveal predominantly classic CNV due to AMD, with maximum benefit seen in the classic with no occult CNV subtype. 2 Lesion size is also a predictive factor for the magnitude of treatment benefit with photodynamic therapy. 3 The aim of this retrospective study was to evaluate if lesion size and final lesion characteristics determined the success rate of PDT for subfoveal classic with no occult CNV lesions.
Methods
This study was conducted in a specialist macula clinic in a district general hospital. We reviewed the case-notes and fluorescein angiography (FFA) of 30 consecutive patients with subfoveal classic with no occult CNV due to AMD who were treated with PDT according to the TAP study protocol. Digital fluorescein angiography was performed in all cases on initial visit and all 3-monthly follow-ups.
The total area of the lesion was defined as the area covered by the classic CNV plus blocked fluorescence. The blocked fluorescence corresponded to blood, fibrosis or pigment. The greatest linear diameter (GLD) was measured on one of a suitable stereo pair of angiographic frames using the digital angiogram software (Digital Healthcare). The lesion size was classified into four groups: o750, 751-1500, 1501-3000, and 43001mm.
The GLD of the initial lesion was determined from the first FFA. The need for repeated treatment was determined by the retinal specialist, taking into account the visual acuity, clinical appearance and angiographic features. The final lesion GLD was determined from the FFA performed 3 months following the final treatment.
In addition, the final lesion characteristics were classified into two groups:
1. Involution of CNV with retinal pigmentary disturbances (RPE changes) 2. Fibrotic lesion Visual acuity was measured by ETDRS chart at 2 m at all visits. Treatment with PDT was defined as successful if the patient lost fewer than 15 letters from baseline.
Logistic regression analysis of the corelation between change in visual acuity and the GLD of lesion at presentation and GLD at final FFA was performed. In addition, we looked for correlation of lesion size and the number of treatments and whether visual outcome was influenced by final lesion characteristics.
Results
The demographic details of 30 consecutive patients treated with PDT are shown in Table 1 .
A total of 60% (18/30) benefited from the therapy with loss of fewer than 15 letters on ETDRs chart.
The effect of initial lesion size on final visual acuity is shown in Table 2 Logistic regression analysis showed that with increasing initial size, the success rate decreased (P ¼ 0.04). Table 3 shows the effect of final lesion size on final visual acuity. Larger final lesion size was associated with lower odds of success (P ¼ 0.03).
The final lesion characteristics did not affect the final visual outcome as shown in Table 4 .
The mean number of treatments per eye was 3.2. The number of treatments did not correlate with initial lesion size (r ¼ 0.21) or final lesion size (r ¼ 0.34).
Discussion
This retrospective study shows that initial and final lesion size determined the final visual outcome in this cohort of patients with predominantly classic with no occult subfoveal CNV. The smaller initial and final lesions were associated with higher odds of success.
The TAP I and II studies showed that the effectiveness of PDT depended on lesion composition and recommended PDT for predominantly classic CNV. Subgroup analysis showed that the predominantly classic with no occult group responded better to PDT. 2 The TAP report III determined the effects of lesion size on outcomes of PDT in the same cohort. The mean lesion size of predominantly classic CNV was noted to be smaller than the other CNV subtypes. 3 This was substantiated by other studies 4, 5 . In addition, smaller subfoveal lesion size was significantly associated with beneficial treatment response from PDT in the minimally classic and occults with no classic group. A similar association was noted in the predominantly classic group but it did not reach significance 3, 6 . Photodynamic therapy for age-related macular degeneration S Sivaprasad et al
In this study, we included only the classic with no occult group. It shows that smaller initial lesion size in this group is associated with a better response to PDT. As classic with no occult lesions have the maximum treatment benefit with PDT, this study identified that small classic with no occult lesions carried the best visual outcome following PDT. Patient awareness of the disease and its symptoms leading to early referral to a treatment centre may allow more patients to be treated when the lesion is still small, thereby increasing the success rate.
This study also showed that final lesion size determined the success to treatment. However, at present the factors that determine the rate of progression of the lesion size remain unclear.
The number of treatments did not depend on either the initial or final lesion size. Moreover, final lesion characteristics did not affect the visual outcome.
Conclusion
This study provides evidence that both initial and final lesion size determines success with PDT in patients with classic with no occult CNV. Increasing lesion size is associated with poorer visual outcome. Further studies are needed to examine whether the trends identified here approach statistical significance with larger numbers.
